147 related articles for article (PubMed ID: 37100016)
1. The roles of the SOX2 protein in the development of esophagus and esophageal squamous cell carcinoma, and pharmacological target for therapy.
Zhang J; Wang Z; Zhao H; Wei Y; Zhou Y; Zhang S; Zhao J; Li X; Lin Y; Liu K
Biomed Pharmacother; 2023 Jul; 163():114764. PubMed ID: 37100016
[TBL] [Abstract][Full Text] [Related]
2. SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling.
Gao H; Teng C; Huang W; Peng J; Wang C
Int J Mol Sci; 2015 Sep; 16(9):21643-57. PubMed ID: 26370982
[TBL] [Abstract][Full Text] [Related]
3. Stemness state regulators SALL4 and SOX2 are involved in progression and invasiveness of esophageal squamous cell carcinoma.
Forghanifard MM; Ardalan Khales S; Javdani-Mallak A; Rad A; Farshchian M; Abbaszadegan MR
Med Oncol; 2014 Apr; 31(4):922. PubMed ID: 24659265
[TBL] [Abstract][Full Text] [Related]
4. SOX2/SALL4 stemness axis modulates Notch signaling genes to maintain self-renewal capacity of esophageal squamous cell carcinoma.
Forghanifard MM; Kasebi P; Abbaszadegan MR
Mol Cell Biochem; 2021 Feb; 476(2):921-929. PubMed ID: 33098486
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence.
Wu Z; Zhou J; Zhang X; Zhang Z; Xie Y; Liu JB; Ho ZV; Panda A; Qiu X; Cejas P; Cañadas I; Akarca FG; McFarland JM; Nagaraja AK; Goss LB; Kesten N; Si L; Lim K; Liu Y; Zhang Y; Baek JY; Liu Y; Patil DT; Katz JP; Hai J; Bao C; Stachler M; Qi J; Ishizuka JJ; Nakagawa H; Rustgi AK; Wong KK; Meyerson M; Barbie DA; Brown M; Long H; Bass AJ
Nat Genet; 2021 Jun; 53(6):881-894. PubMed ID: 33972779
[TBL] [Abstract][Full Text] [Related]
6. Targeting the SOX2/PARP1 complex to intervene in the growth of esophageal squamous cell carcinoma.
Wang Z; Wang J; Zhao H; Zhao T; Chen Y; Jiang M; Zhang S; Wei Y; Zhang J; Zhou Y; Shi S; Fu Z; Yang Y; Zhang Y; Yang L; Que J; Liu K
Biomed Pharmacother; 2022 Sep; 153():113309. PubMed ID: 35738180
[TBL] [Abstract][Full Text] [Related]
7. SOX2 antagonizes WWC1 to drive YAP1 activation in esophageal squamous cell carcinoma.
Chai Y; Li Q; Zhao H; Zhang Z; Yu X; Pang L; Liu Z; Zhao J; Wang L; Li F
Cancer Med; 2019 Nov; 8(16):7055-7064. PubMed ID: 31560173
[TBL] [Abstract][Full Text] [Related]
8. TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines.
Jiang YY; Jiang Y; Li CQ; Zhang Y; Dakle P; Kaur H; Deng JW; Lin RY; Han L; Xie JJ; Yan Y; Doan N; Zheng Y; Mayakonda A; Hazawa M; Xu L; Li Y; Aswad L; Jeitany M; Kanojia D; Guan XY; Said JW; Yang W; Fullwood MJ; Lin DC; Koeffler HP
Gastroenterology; 2020 Oct; 159(4):1311-1327.e19. PubMed ID: 32619460
[TBL] [Abstract][Full Text] [Related]
9. Sox2 induces tumorigenesis and angiogenesis of early-stage esophageal squamous cell carcinoma through secretion of Suprabasin.
Takahashi K; Asano N; Imatani A; Kondo Y; Saito M; Takeuchi A; Jin X; Saito M; Hatta W; Asanuma K; Uno K; Koike T; Masamune A
Carcinogenesis; 2020 Nov; 41(11):1543-1552. PubMed ID: 32055838
[TBL] [Abstract][Full Text] [Related]
10. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
Gen Y; Yasui K; Nishikawa T; Yoshikawa T
Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
[TBL] [Abstract][Full Text] [Related]
11. GSK3β-driven SOX2 overexpression is a targetable vulnerability in esophageal squamous cell carcinoma.
Kang L; Liu Y; He J; Wang Y; Xue M; Wu X; Wang Z; Zhang Y; Chu M; Li J; Wei W; Li J; Li E; Liao L; Xiao J; Zhang R; Xu L; Wong J
Oncogene; 2023 Jul; 42(30):2297-2314. PubMed ID: 37349645
[TBL] [Abstract][Full Text] [Related]
12. Chlorogenic acid inhibits esophageal squamous cell carcinoma growth in vitro and in vivo by downregulating the expression of BMI1 and SOX2.
Zhan Y; Li R; Feng C; Li X; Huang S; Wang L; Liu Z; Jiang J; Han Y
Biomed Pharmacother; 2020 Jan; 121():109602. PubMed ID: 31707349
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive Exploration to Identify Predictive DNA Markers of ΔNp63/SOX2 in Drug Resistance in Human Esophageal Squamous Cell Carcinoma.
Ooizumi Y; Kojima K; Igarashi K; Tanaka Y; Harada H; Yokota K; Kaida T; Ishii S; Tanaka T; Yokoi K; Nishizawa N; Washio M; Ushiku H; Katoh H; Kosaka Y; Mieno H; Hosoda K; Watanabe M; Katada C; Hiki N; Yamashita K
Ann Surg Oncol; 2019 Dec; 26(13):4814-4825. PubMed ID: 31529309
[TBL] [Abstract][Full Text] [Related]
14. Reciprocal regulation of LINC00941 and SOX2 promotes progression of esophageal squamous cell carcinoma.
Lu JT; Yan ZY; Xu TX; Zhao F; Liu L; Li F; Guo W
Cell Death Dis; 2023 Jan; 14(1):72. PubMed ID: 36717549
[TBL] [Abstract][Full Text] [Related]
15. Two novel splice variants of SOX2OT, SOX2OT-S1, and SOX2OT-S2 are coupregulated with SOX2 and OCT4 in esophageal squamous cell carcinoma.
Shahryari A; Rafiee MR; Fouani Y; Oliae NA; Samaei NM; Shafiee M; Semnani S; Vasei M; Mowla SJ
Stem Cells; 2014 Jan; 32(1):126-34. PubMed ID: 24105929
[TBL] [Abstract][Full Text] [Related]
16. SOX2-silenced squamous cell carcinoma: a highly malignant form of esophageal cancer with SOX2 promoter hypermethylation.
Maehara R; Fujikura K; Takeuchi K; Akita M; Abe-Suzuki S; Karbanová J; Corbeil D; Itoh T; Kakeji Y; Zen Y
Mod Pathol; 2018 Jan; 31(1):83-92. PubMed ID: 28862264
[TBL] [Abstract][Full Text] [Related]
17. lncRNA MIAT promotes esophageal squamous cell carcinoma progression by regulating miR-1301-3p/INCENP axis and interacting with SOX2.
Zhang C; Xie L; Fu Y; Yang J; Cui Y
J Cell Physiol; 2020 Nov; 235(11):7933-7944. PubMed ID: 31943174
[TBL] [Abstract][Full Text] [Related]
18. SOX2 inhibits LLGL2 polarity protein in esophageal squamous cell carcinoma via miRNA-142-3p.
Zhang S; Chen Y; Hu Q; Zhao T; Wang Z; Zhou Y; Wei Y; Zhao H; Wang J; Yang Y; Zhang J; Shi S; Zhang Y; Yang L; Fu Z; Liu K
Cancer Biol Ther; 2022 Dec; 23(1):1-15. PubMed ID: 36131361
[TBL] [Abstract][Full Text] [Related]
19. SOX2 identified as a target gene for the amplification at 3q26 that is frequently detected in esophageal squamous cell carcinoma.
Gen Y; Yasui K; Zen Y; Zen K; Dohi O; Endo M; Tsuji K; Wakabayashi N; Itoh Y; Naito Y; Taniwaki M; Nakanuma Y; Okanoue T; Yoshikawa T
Cancer Genet Cytogenet; 2010 Oct; 202(2):82-93. PubMed ID: 20875870
[TBL] [Abstract][Full Text] [Related]
20. Predicting the molecular role of MEIS1 in esophageal squamous cell carcinoma.
Rad A; Farshchian M; Forghanifard MM; Matin MM; Bahrami AR; Geerts D; A'rabi A; Memar B; Abbaszadegan MR
Tumour Biol; 2016 Feb; 37(2):1715-25. PubMed ID: 26314854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
